Cargando…
Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients
Colorectal cancer (CRC) is a common digestive malignancy and emerging studies have closely linked its initiation and development with gut microbiota changes. Fusobacterium nucleatum (Fn) has been recently identified as a pathogenic bacteria for CRC; however, its prognostic significance for patients...
Autores principales: | Yan, Xuebing, Liu, Liguo, Li, Hao, Qin, Huanlong, Sun, Zhenliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652912/ https://www.ncbi.nlm.nih.gov/pubmed/29081665 http://dx.doi.org/10.2147/OTT.S145949 |
Ejemplares similares
-
Fusobacterium nucleatum and Colorectal Cancer
por: Li, Rongrong, et al.
Publicado: (2022) -
Fusobacterium nucleatum and cancer
por: Alon‐Maimon, Tamar, et al.
Publicado: (2022) -
Fusobacterium nucleatum-positive colorectal cancer
por: Yang, Zhenhua, et al.
Publicado: (2019) -
Fusobacterium nucleatum and colorectal cancer: A review
por: Shang, Fu-Mei, et al.
Publicado: (2018) -
Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer
por: Gao, Yaohui, et al.
Publicado: (2021)